Perospirone is an atypical antipsychotic agent used clinically for the treatment of schizophrenia; it acts as an antagonist at 5-HT2A (Ki = 0.6 nM) and dopamine D2 receptors (Ki = 1.4 nM), and as a partial agonist at 5-HT1A receptors (Ki = 2.9 nM); it has also been used in research studies on schizophrenia and shown to significantly attenuate phencyclidine (PCP)-induced cognitive deficits in mice in a dose-dependent manner.